Literature DB >> 6526138

Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.

T J Wiktor, R I Macfarlan, C M Foggin, H Koprowski.   

Abstract

Eighteen strains of virus were recovered by tissue culture techniques from 20 samples of mouse brain received from Harare, Zimbabwe, and typed with monoclonal antibodies at The Wistar Institute. On the basis of reactivity with these monoclonal antibodies specific for rabies and rabies-related viruses, seven strains were identified as Mokola viruses, and the remaining 11, as rabies viruses. Seventeen of 36 monoclonal antibodies against the nucleocapsid antigen reacted with the Mokola strains, but none of 42 monoclonal antibodies against the glycoprotein that neutralized rabies virus was active against Mokola strains. Mokola virus was, however, neutralized by two monoclonal antibodies produced from mice immunized with Mokola, by a specific anti-Mokola serum prepared in rabbits, and to a lesser extent, by three polyclonal high titer antirabies sera of human or rabbit origin. Immunization of mice with a rabies vaccine (antigenic value, 10 international units) at a concentration 30-fold high than that necessary for complete protection against homologous challenge with rabies virus was not protective against Mokola infection. No cross-reactivity between Mokola and rabies viruses was seen with cytotoxic T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6526138

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  42 in total

1.  Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.

Authors:  B Dietzschold; M Gore; D Marchadier; H S Niu; H M Bunschoten; L Otvos; W H Wunner; H C Ertl; A D Osterhaus; H Koprowski
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice.

Authors:  Milosz Faber; Michael Bette; Mirjam A R Preuss; Rojjanaporn Pulmanausahakul; Jennifer Rehnelt; Matthias J Schnell; Bernhard Dietzschold; Eberhard Weihe
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Immunization of cattle against rabies using inactivated cell culture vaccines.

Authors:  L Sihvonen; K Kulonen; E Neuvonen
Journal:  Acta Vet Scand       Date:  1994       Impact factor: 1.695

4.  Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America.

Authors:  K Morimoto; M Patel; S Corisdeo; D C Hooper; Z F Fu; C E Rupprecht; H Koprowski; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

5.  Immunization against rabies with plant-derived antigen.

Authors:  A Modelska; B Dietzschold; N Sleysh; Z F Fu; K Steplewski; D C Hooper; H Koprowski; V Yusibov
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

6.  Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity.

Authors:  H Badrane; C Bahloul; P Perrin; N Tordo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.

Authors:  Milosz Faber; Rojjanaporn Pulmanausahakul; Suchita S Hodawadekar; Sergei Spitsin; James P McGettigan; Matthias J Schnell; Bernhard Dietzschold
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.

Authors:  J H Nunberg; M V Doyle; S M York; C J York
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

9.  Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.

Authors:  R Pulmanausahakul; M Faber; K Morimoto; S Spitsin; E Weihe; D C Hooper; M J Schnell; B Dietzschold
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.

Authors:  Thomas Müller; Bernhard Dietzschold; Hildegund Ertl; Anthony R Fooks; Conrad Freuling; Christine Fehlner-Gardiner; Jeannette Kliemt; Francois X Meslin; Richard Franka; Charles E Rupprecht; Noël Tordo; Alexander I Wanderler; Marie Paule Kieny
Journal:  PLoS Negl Trop Dis       Date:  2009-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.